Use of a monoclonal antibody in the diagnosis of infection by Dermatophilus congolensis.

This research involved the production of a monoclonal antibody (McAb) to specifically detect the bacteria Dermatophilus congolensis, which causes dermatophilosis in animals. The antibody demonstrated specificity to the bacterium and was successful in identifying the presence of the bacterium in clinical material obtained from animals with confirmed or presumptive dermatophilosis.

Monoclonal Antibody Production

• The specific monoclonal antibody was created from murine (mouse) hybridoma cultures. Hybridomas are artificially created cells used in laboratories for the production of highly specific monoclonal antibodies.
• The produced antibody was then purified using a method known as affinity chromatography. This process helps to isolate and purify the antibody based on its specific interaction or ‘affinity’ towards certain proteins – in this case, proteins associated with Dermatophilus congolensis.

Species Specificity

• Indirect immunofluorescent staining was used to demonstrate the specificity of the antibody. This technique uses fluorescent dye to visualize the antibody-antigen interaction, confirming whether the antibody recognizes Dermatophilus congolensis.
• The monoclonal antibody responded to 10 isolates of D. congolensis but showed no reaction to other bacterial isolates (10 Nocardia species isolates, a Rhodococcus, and a Streptomyces isolate), demonstrating its specificity to D. congolensis.

Clinical Application

• The researchers then applied the monoclonal antibody to detect D. congolensis in clinical samples collected from animals suspected or confirmed to have dermatophilosis, a skin condition caused by the bacterium.
• Indirect immunofluorescent staining was again used to visualize the presence of D. congolensis in the tissue samples, confirming the efficacy of the monoclonal antibody in diagnosing dermatophilosis in livestock.

Overall, the study indicates that monoclonal antibodies could provide a new angle to improve the diagnosis and management of dermatophilosis.